1-20 of 74
Jing Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting Enterobacter cloacae attenuates osteolysis by reducing ammonium in multiple myeloma

Qin Yang, Yinghong Zhu, Xingxing Jian, Yi Qiu, Yan Zhu, Lia Zhao, Yanjuan He, Gang An, Lugui Qiu, Jiaojiao Guo, Nihan He, Huerxidan Abudumijiti, Cong Hu, Xun Chen, Siqing Huang, Xiangling Feng, Xin Li, Jing Liu, Yajing Xu, Wen Zhou
Journal: Blood
Blood blood.2024025694.
https://doi.org/10.1182/blood.2024025694
Published: 2024
Includes: Supplemental data
Journal Articles

SHMT2-Folate-Folate Receptor Axis Impaired Erythropoiesis in Myelodysplastic Syndrome

Chaoying Yang, Haobo Li, Yanpeng Wang, Ling Nie, Zeyuan Wang, Zhiming Guo, Xu Han, Xiuli An, Jing Liu, Ji Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 6693.
https://doi.org/10.1182/blood-2024-209287
Published: 2024
Journal Articles

HDAC Inhibitor Effectively Reverses Stemness Transformation of ETV6::Mecom -Positive Leukemia Cells By Upregulating CDKN1C

Yuchao Hao, Jing Liu, Jiayin Zhou, Jiong Hu, Jinsong Yan
Journal: Blood
Blood (2024) 144 (Supplement 1): 5743.
https://doi.org/10.1182/blood-2024-209276
Published: 2024
Journal Articles

Sex Differences in Disease Characteristics and Outcome in Adults with Acute Myeloid Leukemia from China

Zongru Li, Lu Yu, Li-Juan Hu, Ting Zhao, Wenbing Duan, Jing Wang, Jinsong Jia, Jing Liu, Ya-Zhen Qin, Hao Jiang, Xiaohui Zhang, Feifei Tang, Yuqian Sun, XiaoDong Mo, Lanping Xu, Yu Wang, Xiaojun Huang, Qian Jiang
Journal: Blood
Blood (2024) 144 (Supplement 1): 6121.
https://doi.org/10.1182/blood-2024-211874
Published: 2024
Journal Articles

HLTF Regulates Erythroid Differentiation through Transcription Factors and Chromatin Landscape Modulation

Han Gong, Bin Hu, Wenwen Xu, Pan Wang, Maohua Li, Ling Nie, Huifang Zhang, Li Liu, Yue Sheng, Long Liang, Xu Han, Mohandas Narla, Jing Liu
Journal: Blood
Blood (2024) 144 (Supplement 1): 3845.
https://doi.org/10.1182/blood-2024-207540
Published: 2024
Journal Articles

Genetic Abnormalities Associated with Outcomes in Unfit Patients with Acute Myeloid Leukemia Receiving Less Intensive Therapy in the Real World

Lu Yu, Lijuan Hu, Zongru Li, Ting Zhao, Wenbing Duan, Jing Wang, JinSong Jia, Jing Liu, Ya-Zhen Qin, Hao Jiang, Xiaohui Zhang, Feifei Tang, Yuqian Sun, XiaoDong Mo, LanPing Xu, Yu Wang, Xiaojun Huang, Qian Jiang
Journal: Blood
Blood (2024) 144 (Supplement 1): 1537.
https://doi.org/10.1182/blood-2024-207269
Published: 2024
Journal Articles

Venetoclax with Hypomethylating Agents Compared with Priming Regimens for Newly Diagnosed Patients with Acute Myeloid Leukemia with Myelodysplasia Related Changes: A Single Center Retrospective Study

Fangtong Liu, Chao-Ling Wan, Yu-Qing Liu, Yuan-Hong Huang, Han-Yu Cao, Si-Man Huang, Kai-Wen Tan, Shuai-Shuai Ge, Miao Wang, Mei-Jing Liu, Zihao Wang, Sheng-Li Xue, Haiping Dai
Journal: Blood
Blood (2024) 144 (Supplement 1): 1484.
https://doi.org/10.1182/blood-2024-202500
Published: 2024
Journal Articles

Subgroup Analyses of Phase 2 Study: Evaluating the Efficacy of Fully Human BCMA-Targeting CAR T Cells (Zevorcabtagene Autoleucel) in Patients with Relapsed/Refractory Multiple Myeloma

Wenming Chen, Chengcheng Fu, Baijun Fang, Aibin Liang, Zhongjun Xia, Yanjuan He, Jin Lu, Hui Liu, Ming Hou, Zhen Cai, Wei Yang, Siguo Hao, Songfu Jiang, Hongmei Jing, Jing Liu, Xin Du, Rong Fu, Heng Mei, Zunmin Zhu, Yanli Yang, Hong Liu, Xingxing Meng, Nishanthan Rajakumaraswamy, Wei Zheng, Huamao Wang, Zonghai Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 4762.
https://doi.org/10.1182/blood-2024-204620
Published: 2024
Journal Articles

Impact of CAR T-Cell Persistence on Clinical Outcomes in Relapsed/Refractory Multiple Myeloma: Insights from the Phase 2 Fumanba-1 Study

Chunrui Li, Dehui Zou, Di Wang, Baijun Fang, He Huang, Jianyong Li, Bing Chen, Jing Liu, Xi Zhang, Yujun Dong, Kai Hu, Peng Liu, Jianqing Mi, Kaiyang Ding, Zhenyu Li, Qie Dong, Fuyuan Zhang, Guang Hu, Lu-Gui Qiu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4761.
https://doi.org/10.1182/blood-2024-204355
Published: 2024
Journal Articles

Weekly Selinexor, Bortizomib and Dexamethasone (SVd) Versus Twice Weekly Bortizomib and Dexamethasone (Vd) in Chinese Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Primary Analysis of Phase 3 Bench Study

Jin Lu, Liangquan Geng, Lijuan Chen, Peng Liu, Yuping Zhong, Zhuogang Liu, Zhongjun Xia, Jianqing Mi, Chunrui Li, Xi Zhang, Yanjuan He, Yongqiang Wei, Baijun Fang, Fei Li, Zhen Cai, Yafei Wang, Dongping Huang, Hong Liu, Ming Hou, Rong Fu, Xin Du, Xiaosheng Fang, Qingshu Zeng, Wen Gao, Wei Wang, Chunkang Chang, Guifang Ouyang, Jing Liu, Jianyu Weng, Xiaobing Huang, Yang Yu, Zhi Guo, Jun Zhao, Jian Hou
Journal: Blood
Blood (2024) 144 (Supplement 1): 4748.
https://doi.org/10.1182/blood-2024-202893
Published: 2024
Journal Articles

Efficacy Outcomes and Characteristics of Patients with Multiple Myeloma (MM) Who Achieved Sustained Minimal Residual Disease Negativity after Treatment with Equecabtagene Autoleucel (Eque-cel, CT103A) in Fumanba-1

Chunrui Li, Lu-Gui Qiu, Di Wang, Yongping Song, He Huang, Jianyong Li, Bing Chen, Jing Liu, Yujun Dong, Kai Hu, Peng Liu, Xi Zhang, Jianqing Mi, Zhenyu Li, Kaiyang Ding, Shiyue Zhang, Guang Hu, Wen Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 761.
https://doi.org/10.1182/blood-2023-173427
Published: 2023
Journal Articles

Time to Lymphoma Treatment within 24 Months in Watchful Waiting Follicular Lymphoma Defines Patients at High Risk for Progression: A Multicenter Analysis

Fenghua Gao, Jing Liu, Jiesong Wang, Lihong Liu, Zhiming Li, Yuqin Song, Xudong Zhang, Hui Zhou, Xiuhua Sun, Wei Zhang, Bing Xu, Liping Su, Wen Shujuan, Rong Tao, Ou Bai, Qingyuan Zhang, Liqun Zou, Xianhuo Wang, Huilai Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4417.
https://doi.org/10.1182/blood-2023-174308
Published: 2023
Journal Articles

Mega-Dose Decitabine Intensified Regimen Is More Effective at Eliminating Pre-HSCT Measurable Residual Disease Compared to the Bu/Cy Regimen: A Multicenter Prospective Phase II Study

Hao Zheng, Meng Lv, Chenhua Yan, Jing Liu, Yuanyuan Zhang, Xiao-Dong Mo, Yuqian Sun, Yu Wang, Xiaohui Zhang, Lanping Xu, Xiao-Jun Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 471.
https://doi.org/10.1182/blood-2023-188932
Published: 2023
Journal Articles

Dynamic Changes in Lysine Succinylation As Important Regulators of Erythropoiesis

Bin Hu, Han Gong, Chaoying Yang, Ling Nie, Ji Zhang, Long Liang, Mohandas Narla, Yue Sheng, Jing Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 2448.
https://doi.org/10.1182/blood-2023-182646
Published: 2023
Journal Articles

High Dimensional Single-Cell Profiling Identifies Immune and Metabolic Heterogeneity in Immune Thrombocytopenia

Li-Ping Yang, Hai-Xia Fu, Peng Zhao, Jin Wu, Qiu-Sha Huang, Yuan-Yuan Zhang, Jun Kong, Zhi-Dong Wang, Jing Liu, Kaiyan Liu, Xiao Jun Huang, Xiaohui Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 2585.
https://doi.org/10.1182/blood-2023-185457
Published: 2023
Journal Articles

Efficacy, Safety, and Survival Findings after Long-Term Follow-up from ZGJAK002, a Phase 2 Study Comparing Jaktinib 100 Mg Twice Daily with 200 Mg Once Daily for Myelofibrosis (MF)

Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huanling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jianda Hu, Yan Li, Yu Hu, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Shanshan Suo, Wenjuan Yu, Jie Jin
Journal: Blood
Blood (2023) 142 (Supplement 1): 1814.
https://doi.org/10.1182/blood-2023-179043
Published: 2023
Journal Articles

Phase II Multicenter, Randomized Controlled Study on Infusion of MSCs at 45 Days after Haplo-Hematopoietic Stem Cell Transplantation in the Prophylaxis of Gvhd

Ruihao Huang, Ting Chen, Sanbin Wang, Jishi Wang, Yi Su, Jing Liu, Peiyan Kong, Cheng Zhang, Lei Gao, Li Gao, Xi Zhang
Journal: Blood
Blood (2022) 140 (Supplement 1): 7651–7652.
https://doi.org/10.1182/blood-2022-169431
Published: 2022
Journal Articles

Phase Ⅱ Study of Fully Human BCMA-Targeting CAR-T Cells (Zevorcabtagene Autoleucel) in Patients with Relapsed/Refractory Multiple Myeloma

Wenming Chen, Chengcheng Fu, Baijun Fang, Aibin Liang, Zhongjun Xia, Yanjuan He, Jin Lu, Hui Liu, Ming Hou, Zhen Cai, Wei Yang, Siguo Hao, Songfu Jiang, Hongmei Jing, Jing Liu, Xin Du, Rong Fu, Heng Mei, Zunmin Zhu, Yanli Yang, Hong Liu, Daijing Yuan, Hongxia Zhao, Jun Xiao, Wei Wang, Huamao Wang, Zonghai LI
Journal: Blood
Blood (2022) 140 (Supplement 1): 4564–4565.
https://doi.org/10.1182/blood-2022-168610
Published: 2022
Journal Articles

Updated Results of Fumanba-1: A Phase 1b/2 Study of a Novel Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT103A) in Patients with Relapsed and/or Refractory Multiple Myeloma

Chunrui Li, Di Wang, Baijun Fang, Yongping Song, He Huang, Jianyong Li, Dehui Zou, Bing Chen, Jing Liu, Yujun Dong, Hanyun Ren, Kai Hu, Peng Liu, Xi Zhang, Jian-Qing Mi, Zhenyu Li, Kaiyang Ding, Jue Wang, Liting Chen, Aining Xu, Songbai Cai, Jingwen Zeng, Jingjing Guo, Hongyu Gui, Wen Wang, Lugui Qiu
Journal: Blood
Blood (2022) 140 (Supplement 1): 7435–7436.
https://doi.org/10.1182/blood-2022-166465
Published: 2022
Journal Articles

Excess heme upregulates heme oxygenase 1 and promotes cardiac ferroptosis in mice with sickle cell disease

Brief Report
Archita Venugopal Menon, Jing Liu, Hanting Phoebe Tsai, Lingxue Zeng, Seungjeong Yang, Aarti Asnani, Jonghan Kim
Journal: Blood
Blood (2022) 139 (6): 936–941.
https://doi.org/10.1182/blood.2020008455
Published: 2022
Includes: Supplemental data